Sanofi Korea Corporation (hereinafter referred to as Sanofi) successfully concluded the RSV story contest\ for parents who ...

Moreover, French multinational Sanofi bagged the global rights of Enjaymo ... In the world of antibody-drug conjugates (ADCs) ...

Chronic Lower Back Pain (CLBP) market Research Report Covers, Future Trends, Past, Present Data and Deep Analysis ...

This eases the user's understanding of the market thoroughly, while also gaining knowledge about Anxiety Disorder Treatment market opportunities and the dominant players Pfizer Inc, Merck KGaA, Sanofi ...

Sanofi has a hybrid workplace where employees decide how they want to work. We realise the value of diversity and offer a range of benefits for the health of our employees and their families We work ...

Sanofi has joined a growing list of drugmakers going after alpha-synuclein targeting drugs for Parkinson's disease, licensing a bispecific antibody from South Korea's ABL Bio in a deal that could ...

The S&P 500 fell 1.3 per cent on Friday, bringing its losses for the week to 2.1 per cent, its steepest drop since early September. The Nasdaq Composite fell 2.2 per cent on Friday and 3.1 per cent ...

The "CC Chemokine Receptor Type 5 Market Report 2024" report has been added to ResearchAndMarkets.com's offering.The CC ...

The deal gave Sanofi a co-exclusive licence to co-commercialise Novavax’s current stand-alone adjuvanted COVID-19 vaccine ...

A news report from english.shanghai.gov.cn Country Exhibition As a key highlight of the China International Import Expo, the ...

During the session, the Nifty rose as much as 1.34% to 24,537.60, and the Sensex jumped 1.38% to 80,569.73. In terms of intraday gain, the Nifty recorded the best session since Sept. 20, and Sensex ...